Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/1193
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?
Hong, X
Xiong, J
Feng, Z
Shi, Y
Acceso Abierto
Atribución-NoComercial-SinDerivadas
Highlights • ECMO has been used as a rescue therapy for severe respiratory failure and ARDS for years and ECMO should also be considered as a rescue therapy for COVID-19 with refractory hypoxemia despite lung-protective ventilation according to WHO. • Although the clinical trials of ECMO for COVID-19 are lacking, its use in COVID-19 might also offer promise based on the previous experience. • In the current situation of pandemic outbreak, many issues of ECMO use deserve our attention.
International Journal of Infectious Diseases
2020
Preimpreso
https://coronavirus.1science.com/item/efeb6e11f8f6bd119ace67e2b4591d130bf9d5de
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
106461.pdf1.47 MBAdobe PDFView/Open